FDA smoke-study failures are usually protocol and execution failures—not merely fog failures.

What FDA scrutiny repeatedly exposes

FDA aseptic-processing guidance and enforcement actions emphasize protection of exposed sterile product and product-contact surfaces. Recent warning letters have criticized studies that fail to represent actual equipment positions, operator interactions or the full critical area.

Design around the contamination risk

• Identify critical surfaces and product exposure
• Map first-air pathways
• Include routine and non-routine interventions
• Use actual equipment, materials and operator positions
• Record views that show the full airflow path
• Prevent the fog source or technician from obscuring the evidence

Control the fog source

Rapid or erratic source movement can create misleading behavior. Use stable, deliberate positioning and accessories that place the release point without forcing the operator into the critical field.

Create video evidence that survives review

Use adequate contrast, fixed and mobile camera views where needed, timestamps or study identifiers, intervention labels and a narrative linking each sequence to the approved protocol. Preserve original files and document edits used in the final study report.